HEALTHCARE SERVICES GROUP (HCSG) Fundamental Analysis & Valuation

NASDAQ:HCSG • US4219061086

20.04 USD
-0.1 (-0.5%)
At close: Mar 11, 2026
20.04 USD
0 (0%)
After Hours: 3/11/2026, 8:01:22 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This HCSG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Overall HCSG gets a fundamental rating of 5 out of 10. We evaluated HCSG against 82 industry peers in the Commercial Services & Supplies industry. HCSG has an excellent financial health rating, but there are some minor concerns on its profitability. HCSG is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. HCSG Profitability Analysis

1.1 Basic Checks

  • In the past year HCSG was profitable.
  • HCSG had a positive operating cash flow in the past year.
  • Each year in the past 5 years HCSG has been profitable.
  • HCSG had a positive operating cash flow in 4 of the past 5 years.
HCSG Yearly Net Income VS EBIT VS OCF VS FCFHCSG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.44%, HCSG is in the better half of the industry, outperforming 79.27% of the companies in the same industry.
  • HCSG has a better Return On Equity (11.58%) than 68.29% of its industry peers.
  • The Return On Invested Capital of HCSG (6.29%) is better than 64.63% of its industry peers.
  • HCSG had an Average Return On Invested Capital over the past 3 years of 5.87%. This is below the industry average of 10.60%.
  • The last Return On Invested Capital (6.29%) for HCSG is above the 3 year average (5.87%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.44%
ROE 11.58%
ROIC 6.29%
ROA(3y)5.74%
ROA(5y)5.59%
ROE(3y)9.29%
ROE(5y)9.23%
ROIC(3y)5.87%
ROIC(5y)6.53%
HCSG Yearly ROA, ROE, ROICHCSG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • With a decent Profit Margin value of 3.21%, HCSG is doing good in the industry, outperforming 62.20% of the companies in the same industry.
  • In the last couple of years the Profit Margin of HCSG has declined.
  • HCSG's Operating Margin of 2.64% is in line compared to the rest of the industry. HCSG outperforms 47.56% of its industry peers.
  • HCSG's Operating Margin has declined in the last couple of years.
  • HCSG has a worse Gross Margin (13.03%) than 84.15% of its industry peers.
  • In the last couple of years the Gross Margin of HCSG has declined.
Industry RankSector Rank
OM 2.64%
PM (TTM) 3.21%
GM 13.03%
OM growth 3Y-5.85%
OM growth 5Y-16.88%
PM growth 3Y16.23%
PM growth 5Y-10.53%
GM growth 3Y4.36%
GM growth 5Y-3.06%
HCSG Yearly Profit, Operating, Gross MarginsHCSG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. HCSG Health Analysis

2.1 Basic Checks

  • HCSG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, HCSG has less shares outstanding
  • Compared to 5 years ago, HCSG has less shares outstanding
  • HCSG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HCSG Yearly Shares OutstandingHCSG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
HCSG Yearly Total Debt VS Total AssetsHCSG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 6.60 indicates that HCSG is not in any danger for bankruptcy at the moment.
  • HCSG has a Altman-Z score of 6.60. This is amongst the best in the industry. HCSG outperforms 85.37% of its industry peers.
  • There is no outstanding debt for HCSG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.6
ROIC/WACC0.72
WACC8.79%
HCSG Yearly LT Debt VS Equity VS FCFHCSG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • HCSG has a Current Ratio of 3.38. This indicates that HCSG is financially healthy and has no problem in meeting its short term obligations.
  • HCSG has a better Current ratio (3.38) than 85.37% of its industry peers.
  • A Quick Ratio of 3.28 indicates that HCSG has no problem at all paying its short term obligations.
  • HCSG has a Quick ratio of 3.28. This is amongst the best in the industry. HCSG outperforms 87.80% of its industry peers.
Industry RankSector Rank
Current Ratio 3.38
Quick Ratio 3.28
HCSG Yearly Current Assets VS Current LiabilitesHCSG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. HCSG Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 172.22% over the past year.
  • HCSG shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.18% yearly.
  • Looking at the last year, HCSG shows a small growth in Revenue. The Revenue has grown by 7.08% in the last year.
  • The Revenue has been growing slightly by 0.86% on average over the past years.
EPS 1Y (TTM)172.22%
EPS 3Y46.87%
EPS 5Y2.18%
EPS Q2Q%175%
Revenue 1Y (TTM)7.08%
Revenue growth 3Y2.82%
Revenue growth 5Y0.86%
Sales Q2Q%6.59%

3.2 Future

  • Based on estimates for the next years, HCSG will show a decrease in Earnings Per Share. The EPS will decrease by -2.64% on average per year.
  • The Revenue is expected to grow by 5.12% on average over the next years.
EPS Next Y-34.26%
EPS Next 2Y-13.33%
EPS Next 3Y-2.64%
EPS Next 5YN/A
Revenue Next Year5.28%
Revenue Next 2Y5.25%
Revenue Next 3Y5.12%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HCSG Yearly Revenue VS EstimatesHCSG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
HCSG Yearly EPS VS EstimatesHCSG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

4

4. HCSG Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.63, the valuation of HCSG can be described as correct.
  • Based on the Price/Earnings ratio, HCSG is valued cheaper than 84.15% of the companies in the same industry.
  • HCSG is valuated rather cheaply when we compare the Price/Earnings ratio to 26.15, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 20.74 indicates a rather expensive valuation of HCSG.
  • HCSG's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HCSG is cheaper than 71.95% of the companies in the same industry.
  • HCSG is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.27, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.63
Fwd PE 20.74
HCSG Price Earnings VS Forward Price EarningsHCSG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as HCSG.
  • Based on the Price/Free Cash Flow ratio, HCSG is valued cheaper than 89.02% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.12
EV/EBITDA 18.33
HCSG Per share dataHCSG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • HCSG's earnings are expected to decrease with -2.64% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)6.27
EPS Next 2Y-13.33%
EPS Next 3Y-2.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HCSG Dividend Analysis

5.1 Amount

  • HCSG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HCSG Fundamentals: All Metrics, Ratios and Statistics

HEALTHCARE SERVICES GROUP

NASDAQ:HCSG (3/11/2026, 8:01:22 PM)

After market: 20.04 0 (0%)

20.04

-0.1 (-0.5%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)02-11
Earnings (Next)04-21
Inst Owners105.78%
Inst Owner Change-3.46%
Ins Owners1.29%
Ins Owner Change2.45%
Market Cap1.41B
Revenue(TTM)1.84B
Net Income(TTM)59.06M
Analysts80
Price Target24.99 (24.7%)
Short Float %2.67%
Short Ratio2.25
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)138.38%
Min EPS beat(2)87.55%
Max EPS beat(2)189.22%
EPS beat(4)4
Avg EPS beat(4)75.83%
Min EPS beat(4)1.3%
Max EPS beat(4)189.22%
EPS beat(8)5
Avg EPS beat(8)22.26%
EPS beat(12)7
Avg EPS beat(12)4.06%
EPS beat(16)9
Avg EPS beat(16)9.47%
Revenue beat(2)0
Avg Revenue beat(2)-1.59%
Min Revenue beat(2)-2.07%
Max Revenue beat(2)-1.11%
Revenue beat(4)0
Avg Revenue beat(4)-1.17%
Min Revenue beat(4)-2.07%
Max Revenue beat(4)-0.28%
Revenue beat(8)0
Avg Revenue beat(8)-1.51%
Revenue beat(12)0
Avg Revenue beat(12)-2.02%
Revenue beat(16)1
Avg Revenue beat(16)-1.66%
PT rev (1m)13.95%
PT rev (3m)13.95%
EPS NQ rev (1m)-1.11%
EPS NQ rev (3m)-7.29%
EPS NY rev (1m)-1.1%
EPS NY rev (3m)-5.06%
Revenue NQ rev (1m)-1.95%
Revenue NQ rev (3m)-2.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.25%
Valuation
Industry RankSector Rank
PE 13.63
Fwd PE 20.74
P/S 0.77
P/FCF 10.12
P/OCF 9.71
P/B 2.76
P/tB 3.33
EV/EBITDA 18.33
EPS(TTM)1.47
EY7.34%
EPS(NY)0.97
Fwd EY4.82%
FCF(TTM)1.98
FCFY9.88%
OCF(TTM)2.06
OCFY10.29%
SpS26.14
BVpS7.26
TBVpS6.03
PEG (NY)N/A
PEG (5Y)6.27
Graham Number15.5
Profitability
Industry RankSector Rank
ROA 7.44%
ROE 11.58%
ROCE 7.78%
ROIC 6.29%
ROICexc 8.6%
ROICexgc 10.62%
OM 2.64%
PM (TTM) 3.21%
GM 13.03%
FCFM 7.57%
ROA(3y)5.74%
ROA(5y)5.59%
ROE(3y)9.29%
ROE(5y)9.23%
ROIC(3y)5.87%
ROIC(5y)6.53%
ROICexc(3y)7.65%
ROICexc(5y)8.71%
ROICexgc(3y)9.39%
ROICexgc(5y)10.93%
ROCE(3y)7.36%
ROCE(5y)8.23%
ROICexgc growth 3Y-4.73%
ROICexgc growth 5Y-20.16%
ROICexc growth 3Y-4.1%
ROICexc growth 5Y-20.1%
OM growth 3Y-5.85%
OM growth 5Y-16.88%
PM growth 3Y16.23%
PM growth 5Y-10.53%
GM growth 3Y4.36%
GM growth 5Y-3.06%
F-Score8
Asset Turnover2.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 34.68%
Cap/Sales 0.32%
Interest Coverage 28.89
Cash Conversion 221.95%
Profit Quality 235.61%
Current Ratio 3.38
Quick Ratio 3.28
Altman-Z 6.6
F-Score8
WACC8.79%
ROIC/WACC0.72
Cap/Depr(3y)38.6%
Cap/Depr(5y)37.71%
Cap/Sales(3y)0.34%
Cap/Sales(5y)0.33%
Profit Quality(3y)132.28%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)172.22%
EPS 3Y46.87%
EPS 5Y2.18%
EPS Q2Q%175%
EPS Next Y-34.26%
EPS Next 2Y-13.33%
EPS Next 3Y-2.64%
EPS Next 5YN/A
Revenue 1Y (TTM)7.08%
Revenue growth 3Y2.82%
Revenue growth 5Y0.86%
Sales Q2Q%6.59%
Revenue Next Year5.28%
Revenue Next 2Y5.25%
Revenue Next 3Y5.12%
Revenue Next 5YN/A
EBIT growth 1Y20.06%
EBIT growth 3Y-3.19%
EBIT growth 5Y-16.16%
EBIT Next Year837.83%
EBIT Next 3Y132.92%
EBIT Next 5YN/A
FCF growth 1Y468.75%
FCF growth 3YN/A
FCF growth 5Y-8.15%
OCF growth 1Y370.65%
OCF growth 3YN/A
OCF growth 5Y-7.77%

HEALTHCARE SERVICES GROUP / HCSG FAQ

What is the ChartMill fundamental rating of HEALTHCARE SERVICES GROUP (HCSG) stock?

ChartMill assigns a fundamental rating of 5 / 10 to HCSG.


Can you provide the valuation status for HEALTHCARE SERVICES GROUP?

ChartMill assigns a valuation rating of 4 / 10 to HEALTHCARE SERVICES GROUP (HCSG). This can be considered as Fairly Valued.


Can you provide the profitability details for HEALTHCARE SERVICES GROUP?

HEALTHCARE SERVICES GROUP (HCSG) has a profitability rating of 5 / 10.


Can you provide the financial health for HCSG stock?

The financial health rating of HEALTHCARE SERVICES GROUP (HCSG) is 9 / 10.


What is the earnings growth outlook for HEALTHCARE SERVICES GROUP?

The Earnings per Share (EPS) of HEALTHCARE SERVICES GROUP (HCSG) is expected to decline by -34.26% in the next year.